Lasagas, Clemzy O.

HRN: 27-37-97  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/30/2025
07/10/2025
IV
80mg
Q8h
AGE With Mod DHN
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines